Early Trial Results Support the Safety of Cell-Based Retinitis Pigmentosa Treatment
July 15, 2016 – Regenerative medicine company jCyte and the Sue & Bill Gross Stem Cell Research Center at the University of California, Irvine report their […]
News
Klassen Honored as Top Ophthalmologist
The Ophthalmologist has honored Dr. Henry Klassen as one of the 100 most influential people in ophthalmology. The second annual Ophthalmologist Power List notes Dr. Klassen’s longstanding efforts to […]
Stem Cell Treatment Improves Woman’s Sight
Vanna Belton was essentially blind for more than five years before an unconventional stem cell study helped her regain limited vision. But even the study’s […]
Stem Cells used to Regrow Corneal Tissue
In two separate studies, researchers have used human cells reprogrammed to become stem cells to generate transplantable cornea tissue. The first study used the stem cell-generated tissue to repair corneas […]
jCyte Top Stem Cell Story for 2015
The Stem Cellar, California Institute for Regenerative Medicine’s (CIRM’s) official blog, recently posted its top 10 stories from 2015. Not surprisingly, a story about jCyte ranked first. The story, CIRM-Funded UC-Irvine […]
News from our Retinitis Pigmentosa Clinical Trial
I am pleased to give a quick update on the trial, which is going well. Four patients who have been severely affected by retinitis pigmentosa have […]
UCI-Led Team Begins First Clinical Trial of Stem Cell-Based Retinitis Pigmentosa Treatment
August 12, 2015 Participants are being enrolled in the first clinical trial that tests the use of retinal progenitor cells to treat retinitis pigmentosa, reported […]
CIRM-Funded Therapy for Blinding Disease Treats First Patients
August 11, 2015 A clinical trial using stem cells to treat people who have lost their vision due to retinitis pigmentosa (RP) has treated its […]
FDA greenlights UCI clinical trial of treatment for retinitis pigmentosa
July 28, 2015 A first-of-its-kind stem cell-based retinitis pigmentosa treatment developed by UC Irvine’s Dr. Henry Klassen, Dr. Jing Yang and colleagues has received consent […]
CIRM-Funded Therapy for Disease that Attacks Vision Gets Go Ahead for Clinical Trial
June 10, 2015 A novel stem cell therapy for a disease that slowly destroys a person’s vision has been given approval to start a clinical […]